Latest Articles
United States Endometriosis Therapeutics Market Growth Fueled - openPR.com
United States Endometriosis Therapeutics Market Growth Fueled openPR.com
Published: Sept. 29, 2025, 7:26 a.m.
What to expect from Karyopharm Therapeutics Inc. in the next 30 days - Watch List & Stepwise Trade Signal Guides - newser.com
What to expect from Karyopharm Therapeutics Inc. in the next 30 days - Watch List & Stepwise Trade Signal Guides newser.com
Published: Sept. 22, 2025, 7:20 a.m.
EndoCyclic Therapeutics Awarded Rare NIH "Perfect 10" Grant for Endometriosis Therapeutic - BioSpace
EndoCyclic Therapeutics Awarded Rare NIH "Perfect 10" Grant for Endometriosis Therapeutic BioSpace
Published: Sept. 17, 2025, 7:44 a.m.
EndoCyclic Therapeutics Awarded Rare NIH "Perfect 10" Grant for Endometriosis Therapeutic - biospace.com
EndoCyclic Therapeutics Awarded Rare NIH "Perfect 10" Grant for Endometriosis Therapeutic biospace.com
Published: Sept. 17, 2025, 7:44 a.m.
EndoCyclic Therapeutics Awarded Rare NIH "Perfect 10" Grant for Endometriosis Therapeutic - PR Newswire
EndoCyclic Therapeutics Awarded Rare NIH "Perfect 10" Grant for Endometriosis Therapeutic PR Newswire
Published: Sept. 16, 2025, 1 p.m.
United States Endometriosis Therapeutics Market Set for Robust - openPR.com
United States Endometriosis Therapeutics Market Set for Robust openPR.com
Published: Sept. 11, 2025, 9:57 a.m.
Real time breakdown of Brainstorm Cell Therapeutics Inc. stock performance - 2025 Analyst Calls & Momentum Based Trading Signals - Newser
Real time breakdown of Brainstorm Cell Therapeutics Inc. stock performance - 2025 Analyst Calls & Momentum Based Trading Signals Newser
Published: Aug. 22, 2025, 6:09 p.m.
Endometriosis-Associated Infertility: Multi-Omics Insights into Pathogenesis and Precision Therapeutics - Frontiers
Endometriosis-Associated Infertility: Multi-Omics Insights into Pathogenesis and Precision Therapeutics Frontiers
Published: Aug. 15, 2025, 1:08 p.m.
Acrivon Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights - The Manila Times
Acrivon Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights The Manila Times
Published: Aug. 13, 2025, 8:31 p.m.
Acrivon Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights - GlobeNewswire
Acrivon Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights GlobeNewswire
Published: Aug. 13, 2025, 8:17 p.m.
Link copied to clipboard!